PAKOLA STEVE

Chief Medical Officer · SEC CIK 1700659
Advertisement

Buy track record

How this insider's open-market purchases have performed
This insider has no open-market purchases in the records we parsed, so there's no buy track record to score. Their full filing history is below.
Advertisement
Open-market buys
$0
0 trades
Open-market sells
$221.7K
2 trades
Net flow
−$221.7K
Net selling
Total filings
9
transactions shown

Full transaction history

All Form 4 activity across every company, newest first
View on SEC EDGAR ↗
RGNX
Sell PAKOLA STEVE · Chief Medical Officer · Open-market sale · filed May 13, 2026 ΔOwn −6.2%

Pakola Steve sold $168.7K of RGNX, trimming their stake 6%.

−$168.7K
15,309 sh @ $11
RGNX
Sell PAKOLA STEVE · Chief Medical Officer · Open-market sale · filed Mar 12, 2026 ΔOwn −2.0%

Pakola Steve sold $53K of RGNX, trimming their stake 2%.

−$53K
5,124 sh @ $10
RGNX
Tax withholding PAKOLA STEVE · Chief Medical Officer · Tax withholding · filed Feb 3, 2026 ΔOwn −2.0%
−$58.8K
5,267 sh @ $11
RGNX
Grant/award PAKOLA STEVE · Chief Medical Officer · Grant/award · filed Jan 8, 2026 ΔOwn +34%
+$0
65,847 sh
RGNX
Tax withholding PAKOLA STEVE · Chief Medical Officer · Tax withholding · filed Jan 6, 2026 ΔOwn −8.7%
−$262.8K
18,247 sh @ $14
Advertisement
RGNX
Tax withholding PAKOLA STEVE · Chief Medical Officer · Tax withholding · filed Apr 4, 2025 ΔOwn −2.4%
−$42.5K
5,263 sh @ $8
RGNX
Tax withholding PAKOLA STEVE · Chief Medical Officer · Tax withholding · filed Jan 6, 2025 ΔOwn −8.4%
−$107.4K
13,891 sh @ $8
RGNX
Grant/award PAKOLA STEVE · Chief Medical Officer · Grant/award · filed Jan 6, 2025 ΔOwn +42%
+$0
64,293 sh
RGNX
Grant/award PAKOLA STEVE · Chief Medical Officer · Grant/award · filed Aug 5, 2024 ΔOwn +54%
+$0
58,386 sh

Frequently asked questions

How is PAKOLA STEVE's win rate calculated?

We take every open-market purchase (SEC code P) we can match to a stock price, then compare the split- and dividend-adjusted price on the purchase date to the most recent close. The win rate is the share of those buys currently trading above the purchase price. Sales and share grants are not scored.

Why are some buys not included in the score?

A purchase is excluded if we can't price it — for example if the ticker is missing from the filing, the company has been delisted, or the security isn't a common stock we can match to market data. Excluded counts are shown next to the scored total.

What do the 1M / 3M / 6M / 12M columns mean?

They show each purchase's return after a fixed holding period — one, three, six, and twelve months from the buy date — using split- and dividend-adjusted prices. This separates good entry timing from simply holding a long-running winner. A dash means that horizon hasn't elapsed yet for that trade, or the stock couldn't be priced at that date.

Does a high win rate mean I should copy this insider?

No. Past performance does not predict future results, sample sizes are often small, and an insider's edge in their own company doesn't transfer to yours. This is context, not a recommendation. InsiderSource is not investment advice.

Where does this data come from?

Trades come from PAKOLA STEVE's SEC Form 4 filings on EDGAR. Prices come from public market data and are split/dividend-adjusted. Always verify against the original filings before acting.